查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514966

短效胰島素市場，按藥物、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，短效胰島素市場規模為 75.242 億美元，2024 年至 2032 年複合年成長率為 4.50%。

短效胰島素市場-市場動態

政府預防糖尿病傳播的措施推動市場成長

聯邦、州和市各級的政府政策對於提高醫療保健的品質和安全至關重要。政策、系統和環境（PSE）的變化是預防慢性病長期策略的關鍵組成部分。立法法規和環境改變的目標是使健康的行為更容易實現或更可取，同時使有害的接觸變得更加困難或非法。系統干預措施致力於改善機構或組織的運作以及向社區提供的服務。糖尿病是一種慢性疾病，影響超過 3000 萬人。 2010 年《平價醫療法案》(ACA) 在政府、雇主和個人之間建立了共同責任範式，以確保每個人都能在其所在地區無限制地獲得負擔得起的高品質健康保險。

短效胰島素市場 - 關鍵見解

我們的研究分析師估計，2024年至2032年全球市場將以約4.50%的複合年成長率發展。

根據藥物細分，Novolog 藥物細分市場將在 2023 年主導全球胰島素市場。

按地區分類，北美是 2023 年的主要收入來源

短效胰島素市場-細分分析：

全球短效胰島素市場根據藥物和地區進行細分。

市場根據藥物分為三類：Novolog、Humalog 和 Humulin。到 2023 年，Novolog 藥物領域將主導全球胰島素市場，預計複合年成長率最高。 Novolog 是一種速效胰島素，可與進餐時胰島素協同作用。它的開發主要是為了獲得與非糖尿病患者的胰島素生理進餐反應更密切相關的藥物動力學和藥效學特徵。

短效胰島素市場 - 地理洞察

從地理來看，該市場存在於北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據哪些國家帶來業務進一步分類。北美主導市場。北美作為全球最發達、最大的經濟體，擁有世界一流的醫療設施，這是其市場主導地位的重要基礎。

預計亞太市場在預測期內將成為全球短效胰島素市場中最快的收入成長率；亞太地區的成功可歸因於該地區醫療保健行業的驚人擴張，該行業的快速成長。

短效胰島素市場-競爭格局：

在競爭激烈的短效胰島素市場中，幾家重要的製藥公司都積極參與速效胰島素產品的開發和行銷。這些企業根據產品功效、安全性、成本和市場佔有率進行競爭。短效胰島素產業的一些重要參與者包括賽諾菲、禮來公司、諾和諾德公司、Verily 和 Sensile。

最近的發展：

2021年6月，禮來公司宣布投資4億美元擴大產能。

目錄

第1章：短效胰島素市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物分類的短效胰島素市場片段
    • 按國家/地區分類的短效胰島素市場片段
    • 按地區分類的短效胰島素市場片段
  • 競爭洞察

第 3 章：短效胰島素主要市場趨勢

  • 短效胰島素市場促進因素
    • 市場促進因素的影響分析
  • 短效胰島素市場限制
    • 市場限制影響分析
  • 短效胰島素市場機會
  • 短效胰島素市場未來趨勢

第 4 章：短效胰島素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：短效胰島素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：短效胰島素市場格局

  • 2023 年短效胰島素市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：短效胰島素市場 - 按藥物分類

  • 概述
    • 按藥物分類的細分市場佔有率分析
    • 諾沃洛格
    • 優泌樂
    • 優泌林

第 8 章：短效胰島素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美短效胰島素主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲短效胰島素主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按藥品）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區短效胰島素主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區藥物市場規模與預測
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲短效胰島素主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥品）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲短效胰島素主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥品）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 9 章：主要供應商分析 - 短效胰島素產業

  • 競爭儀表板
  • 公司簡介
    • Novo Nordisk AS
    • Sanofi
    • Eli Lilly and Company
    • Verily
    • Sensile
    • Others

第 10 章：360 度分析師視角

第 11 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3095

REPORT HIGHLIGHT

Short-Acting Insulin Market size was valued at USD 7,524.2 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

The Short-Acting Insulin Market refers to the market segment dealing in insulin medications of a quick onset of action with a short, lengthier duration of effect. Short-acting insulin aims to provide glycemia control immediately post-meal to avoid glucose spikes due to food intake. Short-acting insulin is usually administered before or immediately after meals in order to closely mimic the body's natural supply of insulin to food intake. This is the very market of different pharmaceutical companies producing and distributing such medications to people with diabetes, so that these people may use them in a way of helping their body system regulate its blood sugar level effectively.

Short-Acting Insulin Market- Market Dynamics

Government's Initiatives to Prevent the Spread of Diabetes Drive Market Growth

Government policies at the federal, state, and municipal levels are critical to improving the quality and safety of healthcare. Changes in policy, systems, and the environment (PSE) are critical components of a long-term strategy to prevent chronic diseases. The goal of legislative regulations and environmental alterations is to make healthy behaviours more available or desirable while making detrimental exposures more difficult or illegal. Systemic interventions strive to improve an agency's or organization's operations and service delivery to the community. Diabetes is a chronic condition affecting over 30 million individuals. The Affordable Care Act of 2010 (ACA) established a shared responsibility paradigm among the government, employers, and individuals to ensure that everyone has unlimited access to affordable, high-quality health insurance in their local regions.

Short-Acting Insulin Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 4.50% from 2024 to 2032.

Based on Drug segmentation, the Novolog drugs segment will dominate the worldwide insulin market in 2023.

On the basis of region, North America was the leading revenue generator in 2023

Short-Acting Insulin Market- Segmentation Analysis:

The Global Short-Acting Insulin Market is segmented on the basis of Drug and Region.

The market is divided into three categories based on drugs: Novolog, Humalog, and Humulin. The Novolog drugs segment will dominate the worldwide insulin market in 2023, with the greatest CAGR projected. Novolog is a rapid-acting insulin that works in tandem with mealtime insulin. It was developed largely to attain pharmacokinetic as well as pharmacodynamic features that are more closely related to the physiological mealtime response of insulin in a person without diabetes.

Short-Acting Insulin Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominates the market. North America, the world's most developed and largest economy, has world-class healthcare facilities, which is the major basis for its market dominance.

The Asia-Pacific market is predicted to experience the quickest revenue growth rate in the worldwide Short-Acting Insulin market during the forecast period; the Asia-Pacific region's success can be attributed to the amazing expansion of the region's healthcare industry, which has grown at a rapid pace.

Short-Acting Insulin Market- Competitive Landscape:

In the competitive Short-Acting Insulin Market, several important pharmaceutical companies are actively involved in the development and marketing of rapid-acting insulin products. These businesses compete based on product efficacy, safety, cost, and market presence. Some significant participants in the short-acting insulin industry are Sanofi, Eli Lilly & Company, Novo Nordisk AS, Verily, and Sensile.

Recent Developments:

In June 2021, Eli Lilly and Company announced a $400 million investment to expand its production capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novo Nordisk AS

Sanofi

Eli Lilly and Company

Verily

Sensile

Others

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

  • Novolog
  • Humalog
  • Humulin

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Short-Acting Insulin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Short-Acting Insulin Market Snippet by Drug
    • 2.1.2. Short-Acting Insulin Market Snippet by Country
    • 2.1.3. Short-Acting Insulin Market Snippet by Region
  • 2.2. Competitive Insights

3. Short-Acting Insulin Key Market Trends

  • 3.1. Short-Acting Insulin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Short-Acting Insulin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Short-Acting Insulin Market Opportunities
  • 3.4. Short-Acting Insulin Market Future Trends

4. Short-Acting Insulin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Short-Acting Insulin Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Short-Acting Insulin Market Landscape

  • 6.1. Short-Acting Insulin Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Short-Acting Insulin Market - By Drug

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
    • 7.1.2. Novolog
    • 7.1.3. Humalog
    • 7.1.4. Humulin

8. Short-Acting Insulin Market- By Geography

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Short-Acting Insulin Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.2.5. U.S.
      • 8.2.5.1. Overview
      • 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.5.3. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.2.6. Canada
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.6.3. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Short-Acting Insulin Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.5. Germany
      • 8.3.5.1. Overview
      • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.5.3. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.6. Italy
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.6.3. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.7. United Kingdom
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.7.3. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.8. France
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.8.3. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.9. Russia
      • 8.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.9.2. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.10. Netherlands
      • 8.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.10.2. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.11. Sweden
      • 8.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.11.2. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.12. Poland
      • 8.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.12.2. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.13. Rest of Europe
      • 8.3.13.1. Overview
      • 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.13.3. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Short-Acting Insulin Key Manufacturers in Asia Pacific
    • 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.4.4. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.5. India
      • 8.4.5.1. Overview
      • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.5.3. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.6. China
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.6.3. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.7. Japan
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.7.3. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.8.3. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.9. Australia
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.9.3. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.10. Thailand
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.10.3. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.11. Indonesia
      • 8.4.11.1. Overview
      • 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.11.3. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.12. Philippines
      • 8.4.12.1. Overview
      • 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.12.3. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.13. Rest of APAC
      • 8.4.13.1. Overview
      • 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.13.3. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.5. Latin America
    • 8.5.1. Overview
    • 8.5.2. Short-Acting Insulin Key Manufacturers in Latin America
    • 8.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.5.4. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.5. Brazil
      • 8.5.5.1. Overview
      • 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.5.3. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.6. Mexico
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.6.3. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.7. Argentina
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.7.3. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.8. Colombia
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.8.3. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.9.3. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Overview
    • 8.6.2. Short-Acting Insulin Key Manufacturers in Middle East and Africa
    • 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Overview
      • 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.5.3. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.6. United Arab Emirates
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.6.3. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.7. Israel
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.7.3. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.8. Turkey
      • 8.6.8.1. Overview
      • 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.8.3. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.9. Algeria
      • 8.6.9.1. Overview
      • 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.9.3. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.10. Egypt
      • 8.6.10.1. Overview
      • 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.10.3. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.11. Rest of MEA
      • 8.6.11.1. Overview
      • 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.11.3. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Short-Acting Insulin Industry

  • 9.1. Competitive Dashboard
  • 9.2. Company Profiles
    • 9.2.1. Novo Nordisk AS
    • 9.2.2. Sanofi
    • 9.2.3. Eli Lilly and Company
    • 9.2.4. Verily
    • 9.2.5. Sensile
    • 9.2.6. Others

10. 360 Degree Analyst View

11. Appendix

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Short-Acting Insulin Market: Drug Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global Short-Acting Insulin Market, by Drug 2019-2032 (USD Million)
  • TABLE TABLE TABLE Short-Acting Insulin Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Short-Acting Insulin Market, by Region 2019-2032 (USD Million)
  • TABLE North America Short-Acting Insulin Market, by Country, 2019-2032 (UD Million)
  • TABLE North America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Europe Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Asia Pacific Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Latin America Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)

T

List of Figures

  • FIGURE Short-Acting Insulin Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Drug segment market share analysis, 2023 & 2032
  • FIGURE Drug segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Europe Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Asia Pacific Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Latin America Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Middle East and Africa Short-Acting Insulin Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Germany Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE India Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Brazil Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Saudi Arabia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)